NCT02219516View on ClinicalTrials.gov

Mild, Moderate and Severe Renal Impairment Study

PHASE1CompletedINTERVENTIONAL
Enrollment

31

Participants

Timeline

Start Date

August 1, 2014

Primary Completion Date

October 30, 2015

Study Completion Date

May 13, 2016

Conditions
Gout
Interventions
DRUG

RDEA3170

Trial Locations (4)

32809

Orlando

37920

Knoxville

55404

Minneapolis

80228

Lakewood

Sponsors
All Listed Sponsors
lead

Ardea Biosciences, Inc.

INDUSTRY